Search people, articles, bills, and more
Drug shortages can have serious consequences, leading to delayed treatments, poorer patient outcomes, and increased healthcare costs. This bill addresses a critical vulnerability in the nation's healthcare system: its reliance on often fragile global supply chains for essential medicines and their ingredients. If passed, it would create a safety net, ensuring that even if there are disruptions from natural disasters, pandemics, or geopolitical events, the U.S. would have a ready supply of vital medications. This could prevent widespread health emergencies and alleviate the stress and financial burden that drug shortages place on patients, healthcare providers, and the economy.
Without this bill, the U.S. would remain highly susceptible to drug shortages, which could compromise national health security during future crises. By encouraging domestic manufacturing and maintaining reserves, it aims to build greater self-sufficiency and resilience in the pharmaceutical supply chain, which has been highlighted as a critical need during recent public health emergencies.
No reactions yet. Be the first to weigh in.
Drug shortages can have serious consequences, leading to delayed treatments, poorer patient outcomes, and increased healthcare costs. This bill addresses a critical vulnerability in the nation's healthcare system: its reliance on often fragile global supply chains for essential medicines and their ingredients. If passed, it would create a safety net, ensuring that even if there are disruptions from natural disasters, pandemics, or geopolitical events, the U.S. would have a ready supply of vital medications. This could prevent widespread health emergencies and alleviate the stress and financial burden that drug shortages place on patients, healthcare providers, and the economy.
Without this bill, the U.S. would remain highly susceptible to drug shortages, which could compromise national health security during future crises. By encouraging domestic manufacturing and maintaining reserves, it aims to build greater self-sufficiency and resilience in the pharmaceutical supply chain, which has been highlighted as a critical need during recent public health emergencies.
An AI model extracted this from the bill’s official record and can make mistakes. Check the official text ↗ (opens in new tab)